Vedanta Phase II Data Position It To Chase Seres In C. Difficile Recurrence

 
• By Joseph Haas
  
Bacterias 3D rendering
Vedanta thinks its live biotherapeutic can prevent infection recurrence
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D